InvestorsHub Logo

Really People

03/31/21 8:37 AM

#89171 RE: PRED2020 #89170

While particularly effective against Multidrug Resistant Cancer, we believe Adva-27a can potentially treat all cancer types, particularly those in which Topoisomerase II has been amplified.